Ajust text size (less) Ajust text size (more)
Adjust text size
 

Ventolin and Asmol (salbutamol) CFC-free MDI 100 mcg/200 doses inhalers (certain batches only)

Back to previous page

GlaxoSmithKline (GSK) and Alphapharm, in consultation with the Therapeutic Goods Administration, are undertaking a voluntary recall of several batches of Ventolin and Asmol inhalers due to a fault in the delivery mechanism of a small number of inhalers within each batch. This can lead to less than the full dose being delivered for each puff.

The only batches affected are as follows:

  • Ventolin Batch numbers KN7170, KN7173, KN7178, and KN7179
  • Asmol Batch Numbers KL6790, KL6795, KL6796, KL6797, KL6798, and KL6799

The recall notice is published on the Therapeutic Goods Administration website at http://www.tga.gov.au/safety/alerts-medicine-ventolin-asmol-121224.htm

This item is listed in the following categories: • NewsTGA advice


Back

our vision: Improving Australia's health through excellence in pharmacist care

' • '